About CardioFocus
CardioFocus is a company based in Marlborough (United States) founded in 1990.. CardioFocus has raised $260.86 million across 22 funding rounds from investors including Boston Scientific, SVB and HHS. CardioFocus offers products and services including HeartLight X3 and Centauri System. CardioFocus operates in a competitive market with competitors including AtaCor Medical, AtriCure, Kestra Medical Technologies, EBR Systems and AuriGen Medical, among others.
- Headquarter Marlborough, United States
-
Sectors
Healthcare
-
Email
***********
-
Phone
*********
-
Website
*********
-
Social
*********
- Legal Name Cardiofocus Inc.
-
Annual Revenue
-
Net Profit
-
EBITDA
-
Total Equity Funding
$260.86 M (USD)
in 22 rounds
-
Latest Funding Round
$31.76 M (USD), Series E
Feb 23, 2023
-
Investors
Boston Scientific
& 17 more
-
Employee Count
Employee Count
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of CardioFocus
CardioFocus offers a comprehensive portfolio of products and services, including HeartLight X3 and Centauri System. The company's diverse product and service offerings are designed to meet the evolving needs of its customers, address market demands, and provide comprehensive solutions that drive value creation and customer satisfaction across various segments and use cases.
Provides precise laser technology for atrial fibrillation ablation procedures.
Delivers efficient PFA technology for cardiac arrhythmia management.
Unlock access to complete
Funding Insights of CardioFocus
CardioFocus has successfully raised a total of $260.86M across 22 strategic funding rounds. The most recent funding activity was a Series E round of $31.76 million completed in February 2023. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding Total Funding
- Total Rounds 22
- Last Round Series E — $31.8M
-
First Round
First Round
(06 Jan 2000)
- Investors Count 18
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Feb, 2023 | Amount | Debt – Conventional - CardioFocus | Valuation |
investors |
|
| Feb, 2023 | Amount | Series E - CardioFocus | Valuation |
investors |
|
| Apr, 2022 | Amount | Series E - CardioFocus | Valuation |
investors |
|
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Investors in CardioFocus
CardioFocus has secured backing from 18 investors, including institutional and venture fund investors. Prominent investors backing the company include Boston Scientific, SVB and HHS. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
-
|
Founded Year | Domain | Location | |
|
Early stage VC firm investing in the US and Korea
|
Founded Year | Domain | Location | |
|
-
|
Founded Year | Domain | Location |
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
|
Founded Year | Domain | Location | |
|
Startup ecosystems are ignited through strategic investments by Signite Partners.
|
Founded Year | Domain | Location | |
|
Venture capital is directed toward companies in multiple sectors.
|
Founded Year | Domain | Location | |
|
Venture capital is invested in cybersecurity, fintech, and AI startups.
|
Founded Year | Domain | Location |
Investments & Acquisitions by CardioFocus
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Bionic investment advisor platform
|
2016 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 |
Financial Statements - CardioFocus
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Cardiofocus Comparisons
Competitors of CardioFocus
CardioFocus operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as AtaCor Medical, AtriCure, Kestra Medical Technologies, EBR Systems and AuriGen Medical, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
An implantable pacemaker system is developed for cardiac pacing therapy.
|
|
| domain | founded_year | HQ Location |
Cardiac ablation and occlusion devices for atrial fibrillation are provided.
|
|
| domain | founded_year | HQ Location |
Medical devices are developed to support cardiovascular patients at risk.
|
|
| domain | founded_year | HQ Location |
Wireless cardiac pacing devices are developed for left ventricle stimulation.
|
|
| domain | founded_year | HQ Location |
Trans-septal implants for atrial fibrillation treatment are developed.
|
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Multiple services are booked via an app-based platform.
|
|
| domain | founded_year | HQ Location |
On-demand services are booked through an app-based platform.
|
|
| domain | founded_year | HQ Location |
App based platform offering on demand delivery and ride-hailing services
|
|
| domain | founded_year | HQ Location |
Operates an on-demand hyperlocal delivery app for food and groceries.
|
Latest news on Cardiofocus
Frequently Asked Questions about CardioFocus
When was CardioFocus founded?
CardioFocus was founded in 1990 and raised its 1st funding round 10 years after it was founded.
Where is CardioFocus located?
CardioFocus is headquartered in Marlborough, United States. It is registered at Marlborough, Massachusetts, United States.
Is CardioFocus a funded company?
CardioFocus is a funded company, having raised a total of $260.86M across 22 funding rounds to date. The company's 1st funding round was a Series E of $4M, raised on Jan 06, 2000.
What does CardioFocus do?
CardioFocus was founded in 1990 and is headquartered in Marlborough, United States. The company operates in the medical device sector, specializing in cardiology solutions for atrial fibrillation treatment. The HeartLight Endoscopic Ablation System is utilized to enable visual guidance of laser energy for pulmonary vein isolation during procedures. Products are distributed across Europe and Australia, with FDA approval obtained for the United States market.
Who are the top competitors of CardioFocus?
CardioFocus's top competitors include AtaCor Medical, AtriCure and Kestra Medical Technologies.
What products or services does CardioFocus offer?
CardioFocus offers HeartLight X3 and Centauri System.
Who are CardioFocus's investors?
CardioFocus has 18 investors. Key investors include Boston Scientific, SVB, HHS, Boston University, and Oxford Finance.
Book a demo & talk to our team
Share a few details and we’ll reach out to schedule a session.